Company Filing History:
Years Active: 1995-2000
Title: The Innovative Contributions of Glen M. Lang in Gene Therapy
Introduction
Glen M. Lang, a notable inventor based in Winnipeg, Canada, has made significant strides in the field of gene therapy. With a total of two patents to his name, Lang's work primarily focuses on methods that suppress immune responses during gene therapy applications. His innovative solutions aim to enhance the efficacy of gene therapy by addressing the complex biological challenges involved.
Latest Patents
Glen M. Lang holds two key patents that highlight his contributions to immunology and gene therapy. The first patent, "Method for Gene Therapy Involving Suppression of an Immune Response," delineates a procedure for specifically suppressing a mammal's immune response to a foreign DNA that expresses a necessary gene. This technique is particularly vital for patients undergoing gene therapy, as it mitigates the body's natural defense mechanisms against the introduced DNA.
The second patent, "Method for the Suppression of an Immune Response with Antigen-MPEG," presents a method for reducing the capacity of mammals to mount an immune response against biologically active foreign proteins. This involves administering an immunosuppressive tolerogen corresponding to the foreign proteins, which is conjugated to mono methoxy polyethylene glycol (MPEG) prior to the administration of those proteins.
Career Highlights
Throughout his career, Glen M. Lang has collaborated with prominent institutions that have furthered his research and innovation. He has been associated with the University of Manitoba and Emory University, where he has contributed to various projects aimed at advancing therapeutic techniques in gene therapy and immunology.
Collaborations
Lang has also had the opportunity to work alongside notable colleagues, including Alec Sehon and Judith A. Kapp. Together, they have tackled challenging issues related to immune response in gene therapy, pooling their expertise to develop effective solutions that benefit patients.
Conclusion
Glen M. Lang's contributions to gene therapy represent significant advancements in the medical field. His patented methods for immune response suppression reflect a deep understanding of biological processes and a commitment to improving treatment outcomes for patients undergoing gene therapy. As research continues to evolve, Lang's innovative work is poised to play a crucial role in the future of medical therapies.